Melinda L Telli MD

Oncology•Stanford, CA

Breast Cancer

Associate Professor of Medicine - Oncology, Stanford University Medical Center

Join to View Full Profile

300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-723-0074

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2002 - 2005
George Washington University School of Medicine and Health SciencesClass of 2002

Certifications & Licensure

CA State Medical License 2003 - 2025
FL State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women Start of enrollment: 2000 Oct 01
Completed
Phase 2
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2 Start of enrollment: 2008 Apr 01
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
Vitamin D and Breast Cancer: Does Weight Make a Difference? Start of enrollment: 2011 Nov 01
Terminated
Phase 2
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer Start of enrollment: 2012 Jun 13
Completed
Phase 2
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer Start of enrollment: 2012 Aug 01
Completed
Phase 2
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
Completed
Phase 2
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors Start of enrollment: 2014 Feb 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien
Clinical Breast Cancer. 2025-08-01
Impact of timing and breastfeeding on postpartum breast cancer diagnostic patterns and outcomes.
Daniella Klebaner, Natalie Park, Kimberly Stone, Fauzia Riaz, Susan Crowe
Breast Cancer Research and Treatment. 2025-07-30
A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.
Humaira Noor, Yuanning Zheng, Adam B Mantz, Ryle Zhou, Andrew Kozlov
NPJ Breast Cancer. 2025-07-26

Lectures

Evaluation of homologous recombination deficiency (HRD) status with pathological response to carboplatin +/- veliparib in BrighTNess, a randomized phase 3 study in ear...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Signatera Data from I-SPY 2 Trial to Be Presented at ESMO Breast Annual CongressMay 15th, 2024
NCCN: Updated Guidelines Reflect Advances, ‘Immunotherapy Era’ for Breast CancerApril 15th, 2019
Technique Could Help Identify Patients Who Would Suffer Chemo-Induced Heart DamageApril 18th, 2016
Join now to see all

Professional Memberships